These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15792855)
1. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1. Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855 [TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets. Drikos I; Nounesis G; Vorgias CE Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Williams RS; Green R; Glover JN Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Williams RS; Lee MS; Hau DD; Glover JN Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503 [TBL] [Abstract][Full Text] [Related]
5. Thermal and chemical denaturation of the BRCT functional module of human 53BP1. Thanassoulas A; Nomikos M; Theodoridou M; Stavros P; Mastellos D; Nounesis G Int J Biol Macromol; 2011 Oct; 49(3):297-304. PubMed ID: 21600917 [TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502 [TBL] [Abstract][Full Text] [Related]
7. The BRCT domain is a phospho-protein binding domain. Yu X; Chini CC; He M; Mer G; Chen J Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433 [TBL] [Abstract][Full Text] [Related]
8. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400 [TBL] [Abstract][Full Text] [Related]
9. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721 [TBL] [Abstract][Full Text] [Related]
10. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1. Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993 [TBL] [Abstract][Full Text] [Related]
11. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1. Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035 [TBL] [Abstract][Full Text] [Related]
12. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study. Gough CA; Gojobori T; Imanishi T Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491 [TBL] [Abstract][Full Text] [Related]
13. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo. Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1. Ekblad CM; Wilkinson HR; Schymkowitz JW; Rousseau F; Freund SM; Itzhaki LS J Mol Biol; 2002 Jul; 320(3):431-42. PubMed ID: 12096901 [TBL] [Abstract][Full Text] [Related]
15. Thermal unfolding of human BRCA1 BRCT-domain variants. Nikolopoulos G; Pyrpassopoulos S; Thanassoulas A; Klimentzou P; Zikos C; Vlassi M; Vorgias CE; Yannoukakos D; Nounesis G Biochim Biophys Acta; 2007 Jun; 1774(6):772-80. PubMed ID: 17493881 [TBL] [Abstract][Full Text] [Related]
16. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1. Lokesh GL; Rachamallu A; Kumar GD; Natarajan A Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609 [TBL] [Abstract][Full Text] [Related]
17. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. Williams RS; Glover JN J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738 [TBL] [Abstract][Full Text] [Related]
18. Cancer predisposing mutations in BRCT domains. di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754 [TBL] [Abstract][Full Text] [Related]
19. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Yamane K; Tsuruo T Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869 [TBL] [Abstract][Full Text] [Related]